Merck’s lupus drug fails in SLE cohort of Phase II trial
The drug met the primary endpoint in the same study in patients with CLE.
07 March 2025
07 March 2025
The drug met the primary endpoint in the same study in patients with CLE.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.